Dr Emily Jacobs, MD | |
303 E Matthews Ave, Suite 100, Jonesboro, AR 72401-3150 | |
(870) 207-2926 | |
(870) 207-6309 |
Full Name | Dr Emily Jacobs |
---|---|
Gender | Female |
Speciality | Urology |
Experience | 14 Years |
Location | 303 E Matthews Ave, Jonesboro, Arkansas |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1558673889 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | E-8952 (Arkansas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St Bernards Medical Center | Jonesboro, AR | Hospital |
Arkansas Methodist Medical Center | Paragould, AR | Hospital |
Lawrence Memorial Hospital | Walnut ridge, AR | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
St Bernards Physician Clinics Inc | 7012311269 | 172 |
News Archive
In a recent bioRxiv preprint research paper, scientists from Germany discuss how they made sequence information more easily accessible for epidemiologists and virologists.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that the U.S. Food and Drug Administration (FDA) has tentatively scheduled a Division of Metabolic and Endocrine Drug Products Advisory Committee meeting on December 7, 2010 to review the Company's New Drug Application (NDA) for Contrave® (naltrexone sustained release (SR)/bupropion SR) for the treatment of obesity.
The rate of deaths in Haiti's cholera epidemic slowed on Monday. This followed a multinational medical operation scale up to limit the spread of an outbreak that has killed 259 people in the earthquake-hit country. However Haitian and international health authorities are still bracing for more cases before the epidemic is finally controlled. So far, the epidemic has mostly impacted two rural central Haitian provinces, Artibonite and Center, along with the few isolated cases in the capital Port-au-Prince. Suspected cases have also been reported in the Nord and Sud provinces.
Deep brain stimulation (DBS) of the ventral striatum/anterior limb of the internal capsule is safe and feasible in addressing the affective component of pain in patients with post-stroke pain syndrome.
› Verified 5 days ago
Entity Name | St. Bernards Clinics Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1255632568 PECOS PAC ID: 8921287087 Enrollment ID: O20110121000828 |
News Archive
In a recent bioRxiv preprint research paper, scientists from Germany discuss how they made sequence information more easily accessible for epidemiologists and virologists.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that the U.S. Food and Drug Administration (FDA) has tentatively scheduled a Division of Metabolic and Endocrine Drug Products Advisory Committee meeting on December 7, 2010 to review the Company's New Drug Application (NDA) for Contrave® (naltrexone sustained release (SR)/bupropion SR) for the treatment of obesity.
The rate of deaths in Haiti's cholera epidemic slowed on Monday. This followed a multinational medical operation scale up to limit the spread of an outbreak that has killed 259 people in the earthquake-hit country. However Haitian and international health authorities are still bracing for more cases before the epidemic is finally controlled. So far, the epidemic has mostly impacted two rural central Haitian provinces, Artibonite and Center, along with the few isolated cases in the capital Port-au-Prince. Suspected cases have also been reported in the Nord and Sud provinces.
Deep brain stimulation (DBS) of the ventral striatum/anterior limb of the internal capsule is safe and feasible in addressing the affective component of pain in patients with post-stroke pain syndrome.
› Verified 5 days ago
Entity Name | St Bernards Physician Clinics Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1447923438 PECOS PAC ID: 7012311269 Enrollment ID: O20210810001875 |
News Archive
In a recent bioRxiv preprint research paper, scientists from Germany discuss how they made sequence information more easily accessible for epidemiologists and virologists.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that the U.S. Food and Drug Administration (FDA) has tentatively scheduled a Division of Metabolic and Endocrine Drug Products Advisory Committee meeting on December 7, 2010 to review the Company's New Drug Application (NDA) for Contrave® (naltrexone sustained release (SR)/bupropion SR) for the treatment of obesity.
The rate of deaths in Haiti's cholera epidemic slowed on Monday. This followed a multinational medical operation scale up to limit the spread of an outbreak that has killed 259 people in the earthquake-hit country. However Haitian and international health authorities are still bracing for more cases before the epidemic is finally controlled. So far, the epidemic has mostly impacted two rural central Haitian provinces, Artibonite and Center, along with the few isolated cases in the capital Port-au-Prince. Suspected cases have also been reported in the Nord and Sud provinces.
Deep brain stimulation (DBS) of the ventral striatum/anterior limb of the internal capsule is safe and feasible in addressing the affective component of pain in patients with post-stroke pain syndrome.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Emily Jacobs, MD 303 E Matthews Ave, Suite 100, Jonesboro, AR 72401-3150 Ph: (870) 207-2926 | Dr Emily Jacobs, MD 303 E Matthews Ave, Suite 100, Jonesboro, AR 72401-3150 Ph: (870) 207-2926 |
News Archive
In a recent bioRxiv preprint research paper, scientists from Germany discuss how they made sequence information more easily accessible for epidemiologists and virologists.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that the U.S. Food and Drug Administration (FDA) has tentatively scheduled a Division of Metabolic and Endocrine Drug Products Advisory Committee meeting on December 7, 2010 to review the Company's New Drug Application (NDA) for Contrave® (naltrexone sustained release (SR)/bupropion SR) for the treatment of obesity.
The rate of deaths in Haiti's cholera epidemic slowed on Monday. This followed a multinational medical operation scale up to limit the spread of an outbreak that has killed 259 people in the earthquake-hit country. However Haitian and international health authorities are still bracing for more cases before the epidemic is finally controlled. So far, the epidemic has mostly impacted two rural central Haitian provinces, Artibonite and Center, along with the few isolated cases in the capital Port-au-Prince. Suspected cases have also been reported in the Nord and Sud provinces.
Deep brain stimulation (DBS) of the ventral striatum/anterior limb of the internal capsule is safe and feasible in addressing the affective component of pain in patients with post-stroke pain syndrome.
› Verified 5 days ago
Joseph C Kueter, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 303 E Matthews Ave, Suite 200, Jonesboro, AR 72401 Phone: 870-932-2926 Fax: 870-932-1560 | |
Dr. Enoch Walden Williams, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 3817 S Culberhouse Rd, Jonesboro, AR 72404 Phone: 870-935-4886 Fax: 870-933-6334 | |
Ladd J Scriber, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 303 E Matthews Ave, Suite 200, Jonesboro, AR 72401 Phone: 870-932-2926 Fax: 870-932-1560 | |
Dr. Rudolph Noah Bowens Jr., MD Urology Medicare: Accepting Medicare Assignments Practice Location: 303 E Matthews Ave Ste 100, Jonesboro, AR 72401 Phone: 870-207-2926 | |
Mr. John Melvin Allen, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 4802e Johnson Ave, Jonesboro, AR 72401 Phone: 870-936-8000 Fax: 870-934-3665 | |
Mr. Michael Laurence Suminski, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 4802e Johnson Ave, Jonesboro, AR 72401 Phone: 870-936-8000 Fax: 870-934-3665 |